ENABLE-2 trial

The latest news about ENABLE-2 trial: headlines, AI summaries and the full story from every source.

• Enliven and FDA Agree on Phase 3 Trial Design for Relcobatinib in Chronic Myeloid Leukemia Seeking Alpha · October 7, 2026, 03:12 UTC